Omeros Corporation (NASDAQ:OMER) saw a downside of -0.56% to close Tuesday at $7.12 after subtracting -$0.04 on the day. The 5-day average trading volume is 1,398,160 shares of the company’s common stock. It has gained $7.73 in the past week. An average of 1,624,650 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 889,204.
OMER’s 1-month performance is -55.28% or -$8.51 on its low of $6.51 reached on 10/11/21. The company’s shares have touched a 52-week low of $6.51 and high of $23.85, with the stock’s rally to the 52-week high happening on 02/22/21. YTD, OMER has lost -50.16% or -$7.16. However, the current price is down -70.15%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Jun 17, 118 days have gone by since the last insider trading activity for Omeros Corporation (OMER). Demopulos Gregory A MD (CHAIRMAN, CEO & PRESIDENT) most recently sold 36,857 shares at $14.90 per share on Jun 17. This transaction cost the insider $549,169. CHAIRMAN, CEO & PRESIDENT, Demopulos Gregory A MD, sold 36,856 shares at a price of $15.02 on Jun 15. Then, on Apr 08, CHAIRMAN, CEO & PRESIDENT Demopulos Gregory A MD sold 35,206 shares at a price of $17.76 per share. This transaction amounted to $625,259.
Omeros Corporation (OMER) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.19 for the sector.OMER stock has a beta of 1.06. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 5.70.
Omeros Corporation’s quick ratio for the period ended June 29 was 2.30, with the current ratio over the same period at 2.40 meaning that OMER stock is able to fulfill its debt obligations. In terms of profitability, the gross margin trailing 12 months is 98.70%. The trailing 12-month EBITDA margin is -147.65%. The firm’s gross profit as reported stood at $72.91 million against revenue of $73.81 million.
For the quarterly period ending June 29 this year, Omeros Corporation’s cash and short-term investments amounted to $60.96 million against total debt of $348.86 million. Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 18.32% to $28.82 million, while revenue of $21.06 million was 26.93% off the previous quarter. Analysts expected OMER to announce -$0.57 per share in earnings in its latest quarter, but it posted -$0.46, representing a 19.30% surprise. EBITDA for the quarter stood at more than -$23.66 million. OMER stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 391.69 million, with total debt at $348.86 million. Shareholders hold equity totaling $62.5 million
Let’s look briefly at Omeros Corporation (OMER) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 18.58% to suggest the stock is trending oversold, with historical volatility in this time period at 246.40%.
The stock’s 5-day moving average is $7.12, reflecting a +0.56% or $0.04 change from its current price. OMER is currently trading -54.27% above its 20-day SMA, -52.97% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -52.47% and -52.21% respectively.
Stochastic %K and %D was 4.90% and 5.41% and the average true range (ATR) pointed at 1.00. The RSI (14) points at 20.31%, while the 14-day stochastic is at 6.23% with the period’s ATR at 0.95. The stock’s 9-day MACD Oscillator is pointing at -1.04 and -3.43 on the 14-day charts.
In the most recent analyst report for Omeros Corporation (NASDAQ: OMER), JP Morgan downgraded it to an Underweight rating. They previously had a Neutral rating on the stock. Analysts offering their rating for OMER stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate OMER as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.
What is OMER’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $19.00 and a high of $34.00, with their median price target at $25.00. Looking at these predictions, the average price target given by analysts is for Omeros Corporation (OMER) stock is $25.40.